Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Study data from Sun Yat-Sen University, Department of Gastroenterology update understanding of cancer gene therapy
January 13th, 2009
Data detailed in 'Specific reversal of MDR1/P-gp-dependent multidrug resistance by RNA interference in colon cancer cells' have been presented. According to a study from Guangzhou, People's Republic of China, "No control cell line was available for previous RNA interference studies on reversal of multidrug resistance (MDR) in colon cancer cells. Here, human COLO 320DM, with HT-29 as the control, colon cancer cell lines were used to investigate the reversal of MDR1/P-gp-dependent MDR by siRNA (#4123 and #4029 MDR1 siRNAs) targeting to MDR1 mRNA." "Both siRNAs inhibited expression of MDR1 and P-gp in COLO 320DM. The minimum inhibition concentrations were 5 nmol/l of #4123...
Source: Cancer Weekly (2009-01-13)
|
